MXPA02011623A - Skin care moisturizing and sunscreen compositions comprising organic particulate material. - Google Patents

Skin care moisturizing and sunscreen compositions comprising organic particulate material.

Info

Publication number
MXPA02011623A
MXPA02011623A MXPA02011623A MXPA02011623A MXPA02011623A MX PA02011623 A MXPA02011623 A MX PA02011623A MX PA02011623 A MXPA02011623 A MX PA02011623A MX PA02011623 A MXPA02011623 A MX PA02011623A MX PA02011623 A MXPA02011623 A MX PA02011623A
Authority
MX
Mexico
Prior art keywords
composition according
further characterized
particulate material
organic
skin
Prior art date
Application number
MXPA02011623A
Other languages
Spanish (es)
Inventor
Russell Philip Elliott
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0012565A external-priority patent/GB0012565D0/en
Priority claimed from GB0023336A external-priority patent/GB0023336D0/en
Priority claimed from GB0024372A external-priority patent/GB0024372D0/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MXPA02011623A publication Critical patent/MXPA02011623A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43Guanidines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8123Compositions of homopolymers or copolymers of compounds having one carbon-to-carbon double bond, and at least one being terminated by a halogen; Compositions of derivatives of such polymers, e.g. PVC, PTFE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88Polyamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/412Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a topical cosmetic composition with an aqueous continuous phase, in the form of a lotion, cream or gel, comprising: i) from 0.01% to 25%, by weight, of an organic particulate material having a median particle size of from 0.5 to 30 mm; ii) greater than 8%, by weight, of a humectant selected from glycerine, polyalkylene glycol, urea, D or DL panthenol, hexane 1, 2, 6 triol, guanidine or its derivatives, alkylene glycols such as butylene glycol and propylene glycol, and mixtures thereof; iii) from 2% to 20%, by weight, organic sunscreen.for providing highly efficacious levels of moisturisation and UV protection while maintaining optimum skin feel. Preferred embodiments are oil in water emulsions wherein the particulate material has been pre dispersed within an organosiloxane oil to provide for desired non tacky skin feel.

Description

SOLAR FILTERING AND SOLAR FILTERS FOR SKIN CARE COMPRISING ORGANIC MATERIAL IN PARTICLES FIELD OF THE INVENTION The present invention relates to topical compositions with a continuous aqueous phase, suitable for providing high levels of wetting to a product having very acceptable properties upon contact with the skin. More particularly, the invention relates to topical compositions which, in addition to wetting, also provide protection against the damaging effects of ultraviolet radiation, while maintaining optimal skin contact properties. The compositions of the present invention are especially useful for the treatment of the skin of the face and hands, and also of other areas of the body.
BACKGROUND A feature that has long been the subject of various topical compositions, including skin care compositions, is that they contain ingredients that provide benefits of wetting, skin regulation and skin protection.
UV radiation. These compositions are used both to improve the hydration levels of the skin and to protect the skin against the damaging and damaging effects of ultraviolet radiation. In today's environmental environments, when consumers are increasingly exposed to conditions that dry out the skin a lot, such as in buildings with air conditioning and in places where UV radiation is becoming increasingly harmful as a result of the decrease in the ozone layer, there is a growing demand for skin care products, especially facial products, which protect against these harmful daily attacks and repair the damage that this causes. On the other hand, these beneficial agents for the skin, especially organic sun blockers, water-soluble humectants and vitamins, can be very adherent to skin contact, with the result that compositions containing significant levels of these ingredients have undesirable properties in contact with the skin, among them, which are very greasy, sticky and when applied, it creates rub resistance. In addition, when these high levels of humectants are combined with thickeners, adhesion can be exacerbated. Thus, until now, for the formulation of topical compositions the effective levels of the ingredients that impart benefits have had to be sacrificed, having to minimize those levels, so that the final product has acceptable properties on contact with the skin of the patient. consumer. In summary, to date, to get topical compositions they have acceptable properties in contact with the skin, the tendency is that they contain effective ingredients and high adhesion at levels below the optimum, and as a result, to achieve the desired benefits on the skin, multiple applications are required over a prolonged period. Because the ingredients with the worst adhesion properties are often water soluble, this problem is exacerbated in topical compositions having a continuous aqueous phase. This is because the ingredients with high adhesion properties, when present or solubilized within the aqueous phase, reach high levels of contact with the skin, during application. Therefore, it would be good to have a topical composition with a continuous aqueous phase comprising effective levels of ingredients with beneficial properties for the skin, in particular, with benefits of wetting and protection against UV radiation, while at the same time offering to the consumer acceptable properties when in contact with the skin. To date, in the compositions for skin care the inclusion of particulate materials including both organic and inorganic particles has been reported, to affect the texture of both the skin and the composition itself. See, for example, Quantification of the Soft-Focus Effect. Cosmetics & Toilethes, Vol. 111, July 1996, p. 57-61, which states that skin lines can be physically filled with reflective substances, such as T¡O2. U.S. Patent No. 4,892,726, issued to Toshiba Silicone Co. Ltd, describes the use of powdered polimetilsilsesquioxane in cosmetic and makeup compositions, which are uniform after applying and impart a natural color. These particles are already available in a vapedad of particle size degrees, from Toshiba Silicone Co. Ltd under the name Tospearl®. WO 00/24372 discloses topical compositions comprising from 0.5% to 25% of a particulate material having a refractive index of 1.35 to 1.6 and a particle size of 2μm to 30μm, together with other active ingredients that improve the appearance , such as, for example, vitamin B3 compounds and retinoids, to impart a visual improvement to the skin. The particles shown herein include, similarly, Tospearl® 145A having a median particle size of about 4.5μm. Similarly, the co-pending application PCT / US99 / 04748 presents topical compositions comprising from 0.1% to 10% of organic particulate material, again with a refractive index of 1.3 to 1.7, which are suitable for imparting an essentially immediate improvement in the appearance and contact with the skin. EP-A-692,242 discloses the use of deformable hollow particles with a size of 1 to 250 μm, more preferably 18 μm, to reduce the sticky feel of essentially anhydrous compositions that are rich in fatty substances; EP-A-908,175 presents stable cosmetic compositions comprising at least one fatty phase, cross-linked elastomeric organopolysiloxanes and high levels of organopolysiloxane particles; and the EP-A-790,055 discloses the use of organosi loxane, elastomeric, cross-linked polymers in combination with a fatty phase and, preferably, contained within a fatty phase, to prepare compositions that provide a matte appearance to the skin. These applications present a variety of cosmetic compositions with improved contact properties with the skin and which additionally has better appearance properties in the skin. However, the applications do not present aqueous compositions with very effective levels of agents that provide benefits of wetting and protection against UV radiation. The compositions and exhibitions of the prior art provide useful advances in the technique of cosmetic treatment of the skin, such as in the use of organic particles together with agents that provide benefits to the skin, in the so-called so-called skin-beneficial agents. However, they do not adequately teach the manner of providing both effective levels of ingredients for skin moistening and for protection against UV radiation in a water-based topical composition, which also has acceptable properties on contact with the skin of the skin. consumer. It has been surprising that the negative aspect of high adherence of topical skin care compositions having an aqueous continuous phase and also containing very effective levels of ingredients for the skin has now been discovered.
Wetting and protection against UV radiation can be reduced by including, within the composition, one or more types of organic materials into additional particles, with a defined particle size and a critical surface tension. It is important to note that the improvements in skin contact properties are so considerable that high levels of wetting can be achieved in a formulation together with the protection against UV radiation derived from organic materials. Previously, these combinations would not have been possible due to unacceptable adhesion. In addition, it has also been found that if the organic particulate is previously mixed in a low viscosity organosiloxane oil, the improvements achieved in the skin contacting properties are even greater. Without wanting to be limited by theory, it is believed that the inclusion of particulate materials helps to minimize friction when applying the product. With the application of the product, the particles are located in the waste interface of the product / air, protruding from the surface of the product residue. In this way, the contact of the skin with the residue of the product is minimized and the perception on the skin is improved. To ensure that the particulates are delivered in the most efficient manner to the surface of the skin during application it is preferred that the particulate be pre-mixed in a carrier oil. The particles are completely wetted by the carrier oil and the low viscosity and, therefore, the High mobility of the premix ensures that the particles spread efficiently on the surface of the skin when the product is applied. An object of the present invention is to provide topical compositions having a continuous aqueous phase suitable for imparting to the skin high levels of wetting and protection against UV radiation. Another object of the present invention is to provide topical compositions containing a particulate material, for example, polymethylsilyesquioxane, which neutralizes the adhesion of the formulations to provide the desirable skin contacting properties. Still another object of the present invention is to provide compositions that are useful for providing the desired levels of wetting and protection against UV radiation without the need for multiple applications. These and other objects of this invention will be apparent in the light of the following discussion.
BRIEF DESCRIPTION OF THE INVENTION The present invention relates to a topical cosmetic composition having a continuous aqueous phase, in the form of a lotion, cream or gel, the composition comprising: i) from 0.01% to 25%, by weight, of an organic particulate material which it has a median particle size of 0.5 to 30 μm; ii) more than 8%, by weight, of a humectant selected from glycerin, polyalkylene glycol, urea, panthenol D or DL, hexane-1, 2,6-triol, guanidine or its derivatives, alkylene glycols, such as, for example, butylene glycol and propylene glycol and mixtures thereof; iii) from 2% to 20%, by weight, of an organic sunblock. The compositions are useful for imparting very effective levels of wetting and protection against UV radiation, while maintaining acceptable skin contacting properties. This invention also relates to manufacturing methods for increasing the benefits of skin contact and cosmetic methods to provide the benefits of wetting and protection against UV radiation by topical application of the present compositions.
DETAILED DESCRIPTION OF THE INVENTION All percentages and prtions used herein are expressed by weight of the total composition and all measurements made were made at 25 ° C, unless otherwise indicated. Unless otherwise indicated, all percentages, prtions and levels of the ingredients referred to herein are based on the actual amount of the ingredients and do not include the solvent, fillers or other materials that can be combined with the ingredient in products that are commercially available. All publications cited herein are considered fully incorporated into this description, as a reference, unless otherwise indicated. The term "dermatologically acceptable", as used herein, refers to compositions or components thereof that are suitable for use in contact with human skin without undue toxicity, incompatibility, instability, allergic reaction and the like. The term "safe and effective amount", as used herein, refers to an amount of a compound, component or composition, sufficient to positively induce a positive benefit, preferably, the positive benefit of skin appearance or Skin contact properties, which independently includes the benefits stated herein; however, that amount is low enough to avoid serious side effects, that is, to provide a reasonable risk / benefit ratio within the reach of judicious medical judgment. The active ingredients, as well as other useful ingredients herein, can be categorized or described herein by their cosmetic or therapeutic benefits or by their described form of action. However, it will be understood that the active ingredients, as well as other Useful ingredients herein may, in some cases, provide more than one cosmetic or therapeutic benefit or operate by more than one form of action. Therefore, the classifications herein are made for reasons of convenience and are not intended to limit an ingredient to the particular application indicated or to the applications listed. The elements of these compositions are described below in greater detail.
Essential elements of composition Organic material in particles The composition comprises approximately between 0.01% and 25%, preferably approximately between 0.1% and 15%, more preferably between 0.2% and 5%, of the organic particulate material. What is most preferred is that the organic particulate material has a median particle size of between about 0.5 and 30 μm, preferably about 0.5 to 15 μm, more preferably about 0.7 to 10 μm and with a preference superlative of approximately between 1 and 7.5μm. The median particle size refers to the particulate material in its pure form, that is, in its essentially pure powder form. However, methods intended to measure particle size require that the particulate material be disperse in an inert carrier, for example, pure oil, to measure the particle size distribution. The median particle size can be determined by any method known in the art, such as the use of Coulter counter equipment or the ASTM standard Designation E20 85"Standard Practice for Partial Size Analysis of Particulate Substances in the Range of 0.2 to 75 Micrometers by Optical Microscopy "(Standard practice for the analysis of particulate substances in the range of 0.2 to 75 micrometers by optical spectroscopy), Volume ASTM 14.02, 1993. It is preferred that more than 50%, preferably, more than 60% and, with greater preference, more than 70% of the particles are within the ranges prescribed by the respective median values. Preferred particles are free flowing solid materials. By the term "solid" it is meant that the particles are preferably neither deformable nor elastomeric. The particles are selected from polymers of organosilicon, polyethylene, polyacrylonitrile, polyacrylic acid or derivatives thereof, polymethacrylic acid, polystyrene, polytetrafluoroethylene (PTFE), poly (vinylidene chloride), polyamide and mixtures thereof. More preferably, the organic particulate material is selected from organosilicon polymers and mixtures thereof and, with an even greater preference, from polymethyl silsesquioxane. Copolymers derived from monomers of the aforementioned materials can also be used. Suitable and commercially available examples of the organic particulate material of polymethylsilsquioxane are Tospearl® 145 which has a median particle size of approximately 4.5 μm and Tospearl® 1320 which has a median particle size of 12 μm. A further representative example and commercially available is Fluoropure 100C from Shamrock Inc, which is an organic particulate material of polytetrafluoroethylene. Another representative and commercially available example is the EA-209® from Kobo, which is a copolymer of ethylene and acrylic acid having a median particle size of about 10 μm. The organic particulate material preferably has a critical surface tension less than 50 mN / m, preferably less than 40 mN / m and, more preferably, less than 35 mN / m. Critical surface tension is defined by Drew and Myers in "Surfaces, Interfaces and Colloids, Principles and Applications" 1991 chap. 17, pgs. 364-369, (VCH Publishers Inc, New York) and it is measured, without a doubt, thanks to the measurements of the contact angle of a series of liquids related to different surface tensions, as also described in the aforementioned reference.
Humectants The compositions of the present invention comprise from about 8% to 30%, preferably, from about 8.5% to 20% and, more preferably, from about 9% to 15% in weight, of humectant. Preferred humectants include, but are not limited to, selected glycerin, polyoxyalkylene glycol compounds, urea, panthenol D or DL, hexane-1, 2,6-triol, guanidine or its derivatives, alkylene glycols, such as butylene glycol or propylene glycol. Preferred humectants are glycerin, urea and mixtures thereof. The compounds of the above list can be incorporated individually or in combination. The aforementioned compounds can cause high levels of adhesion, especially when they are used in the preferred levels, greater than 8%. However, it has been found that this adhesion sensation can be effectively neutralized by the use of the humectants in combination with the organic particulate materials, as described in the present invention.
Organic sun blockers The compositions of the present invention comprise an organic sunblock. Suitable sunscreens may have UVA-absorbing properties, UVB-absorbing properties or a mixture thereof. The exact amount of active sunscreen will vary, depending on the desired sun protection factor, that is, the "SPF" of the composition, as well as the desired level of protection against UVA radiation. The compositions of the present invention preferably comprise an SPF of at least 10, preferably at least 15 (the SPF is a commonly used measure of the photoprotection of a sunscreen against erythema). The SPF is defined as the proportion of the ultraviolet energy required to produce minimal erythema in a protected skin, with respect to the energy required to produce the same minimum erythema in the unprotected skin of the same person. Refer to Federal Register, 43, no. 166, pgs. 38206-38269, August 25, 1978). The compositions of the present invention comprise between about 2% and 20%, more often between about 4% and 14% by weight, of the organic sunblock. Sunscreens include, but are not limited to, those found in the CTFA International Cosmetic Ingredient Dictionary and Handbook, 7th ed., Volume 2, p. 1672, edited by Wenninger and McEwen (The Cosmetic, Toiletry, and Fragrance Association, Inc., Washington, DC, 1997). The compositions of the present invention preferably comprise an active agent for the UVA-absorbing solar block, which absorbs UV radiation having a wavelength of approximately between 320 nm and 400 nm. Suitable actives of a UVA-absorbing sunscreen are selected from dibenzoylmethane derivatives, anthranilate derivatives, such as, for example, methylanthranite and homomethyl, 1-N-acetylanthranilate and mixtures thereof. In U.S. Patent No. 4,387,089, awarded to Depolo and in Sunscreens: Development. Evaluation. and Regulatory Aspects edited by N. J. Lowe and N. A. Shaath, Marcel Dekker, Inc. (1990) describes examples of dibenzoylmethane sunblock actives. The active agent for Sun block that absorbs UVA radiation is preferably present in an amount such as to provide protection against broad spectrum UVA radiation, either independently or in combination with other UV protective assets that may be present in the composition. The preferred UVA radiation sunscreen assets are the dibenzoylmethane sunblock actives and their derivatives. These include, but are not limited to, those selected from: 2-methyldibenzoylmethane, 4-methyldibenzoylmethane, 4-isopropyldibenzoylmethane, 4-tert-butyldibenzoylmethane, 2,4-dimethyldibenzoylmethane, 2,5-dimethyldibenzoylmethane, 4,4 ' -diisopropylbenzoylmethane, 4- (1,1-dimethylethyl) -4'-methoxydibenzoylmethane, 2-methyl-5-isopropyl-4'-methoxydibenzoylmethane, 2-methyl-5-tert-butyl-4'-methoxy-dibenzoylmethane, 2, 4-dimethyl-4'-methoxydibenzoylmethane, 2,6-dimethyl-4'-tert-butyl-4'-methoxydibenzoylmethane and mixtures thereof. Preferred dibenzoyl active blocking agents include those selected from: 4- (1,1-dimethylethyl) -4'-methoxydibenzoylmethane, 4-isopropyldibenzoylmethane, and mixtures thereof. An active agent for the most preferred sunblock is 4- (1,1-dimethylethyl) -4'-methoxydibenzoylmethane. The active agent for sun block 4- (1,1-dimethylethyl) -4'-methoxydibenzoylmethane, which is also known as butyl methoxydibenzoylmethane or avobenzone, can be obtained commercially under the names Parsol® 1789 from Givaudan Roure (International) SA (Basel, Switzerland) and Eusolex® 9020 from Merck & Co., Inc. (Whitehouse ion, NJ). Sunblock of 4-isopropyldibenzoylmethane, also known as isopropifibenzoylmethane, is commercially available from Merck, under the name of Eusolex® 8020. The compositions of the present invention preferably further comprise an active agent for solar blocking against UVB radiation, which absorbs UV radiation having a wavelength. approximately between 290 nm and 320 nm. The compositions comprise an amount of the active agent for sunblock against UVB radiation that is safe and effective to provide protection against UVB radiation, either independently or in combination with other active UV protective agents that may be present in the compositions The compositions preferably comprise about 0.1% to 16%, more preferably about 0.1% to 12%, and most preferably about 0.5% to 8% by weight, of the organic sunscreen that absorbs UVB radiation. A wide variety of active agents for sun block against UVB radiation is suitable for use in the present. Exemplary examples of these active agents for sun block, organic, are described in U.S. Pat. 5,087,372 issued on February 11, 1992 to Haffey and others; and U.S. Pat. Nos. 5,073,371 and 5,073,372 granted both on December 17, 1991 to Turner and others The active agents for solar blockade against radiation Preferred UVBs are selected from: 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (referred to as octocrylene), 2-phenyl-benzimidazole-5-sulfonic acid (PBSA), cinnamates and their derivatives, such as 2-ethexyl -p-methoxycinnamate and octyl-p-methoxycinnamate, TEA salicylate, octyldimethyl PABA, camphor derivatives and derivatives thereof, as well as mixtures thereof. Preferred organic blocking active agents are: 2-ethylhexyl-2-cyano-3, 3-diphenylacrylate (referred to as octocrylene), 2-phenyl-benzimidazole-5-sulfonic acid (PBSA), octyl-p-methoxycinnamate and mixtures thereof. Also present in the present are useful salts and neutralized acid forms of acidic sun blockers. When organic sunscreen salts are used in the compositions of the present invention, such as PBSA, they can disturb the action of the thickener, with the result that the final product may have a rheology below optimal. This can be counteracted by the addition of higher levels of thickener, fatty alcohols or nonionic surfactants, in such a way that the rheology of the final product returns to the desired level. To any of the useful compositions of the present invention, an agent can also be added to stabilize the sunscreen against UVA radiation and prevent its photodegradation when exposed to UV radiation and, thus, maintain its protective efficacy against UVA radiation. A wide range of compounds that provide these stabilizing properties have been cited and they must be chosen to comply as a whole with both the solar block against radiation UVA as with composition. Suitable stabilizing agents include, but are not limited to, those described in U.S. Pat. 5,972,316; 5,968,485; 5,935,556; 5,827,508 and in patent WO 00/06110. Preferred examples of stabilizing agents for use in the present invention include: 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (referred to as octocrylene), ethyl-2-cyano-3,3-diphenylacrylate, 2-ethylhexyl-3 , 3-diphenylacrylate, ethyl-3,3-bis (4-methoxyphenyl) acrylate and mixtures thereof. The most preferred stabilizing agent is 2-ethylhexyl-2-cyano-3,3-diphenylacrylate. To any of the useful compositions of the present invention an agent may also be added to improve the utilization of said compositions in the skin, in particular, to improve their resistance to being washed out or rubbed off. A preferred agent that will provide this benefit is a copolymer of ethylene and acrylic acid. Compositions containing this copolymer are presented in U.S. Pat. 4,663,157 of Brock, granted on May 5, 1987.
Balance of Composition The compositions described herein are aqueous emulsions, preferably oil-in-water emulsions and may contain a variety of other optional components suitable to make the compositions more cosmetically acceptable, aesthetic or from some other, or to provide them with additional use benefits, as long as these optional components are physically and chemically compatible with the essential components and the method of preparation, described herein, does not excessively impair stability, efficacy or other benefits. of use associated with the compositions of the present invention. The optional components may be dispersed, dissolved or the like in carrier of the compositions herein. These conventional optional ingredients are well known to those skilled in the art. These include, but are not limited to, emollients, oil absorbers, antimicrobial agents, binders, buffers, denaturants, cosmetic astringents, external analgesics, film formers, humectants, opacifying agents, perfumes, pigments, skin sedatives and curing agents., preservatives, propellants, skin penetration promoters, solvents, suspending agents, emulsifiers, cleaning agents, thickening agents, solubilization agents, waxes, inorganic sun blockers, sunless tanning agents, antioxidants and / or eliminators of radicals, chelating agents, anti-acne agents, anti-inflammatory agents, desquamating / exfoliating agents, organic hydroxy acids, vitamins, natural extracts and inorganic particles, such as silica and boron nitride. The non-exclusive examples of these materials that are described in HariYs Cosmeticology. 7th ed., Harry & amp;; Wiikinson (Hill Publishers, London 1982); in Pharmaceutical Dosaqe Forms- Disperse Systems: Lieberman, Rieger & Banker, Vols. 1 (1988) and 2 (1989); Marcel Decker, Inc .; in The Chemistry and Manufacture of Cosmetics. 2nd ed .. deNavarre (Van Nostrand 1962-1965), and in The Handbook of Cosmetic Science and Technology. 1st ed. Knowlton & Pearce (Elsevier 1993) can also be used in the present invention. Preferred compositions have an apparent viscosity of about 5,000 to 200,000 mPa.s (centipoise). For example, preferred lotions have an apparent viscosity of between about 10,000 and 40,000 mPa.s; Preferred creams have an apparent viscosity of between about 30,000 and 160,000 mPa.s. The apparent viscosity can be determined using a Brookfield DVU RV viscometer with TD spindle at 5rpm or its equivalents. The viscosity in the composition is determined after it has been allowed to stabilize after preparing it, in general, at least 24 hours, under conditions of ambient pressure and 25 ° C after the preparation of the composition. The apparent viscosity is measured when the composition has a temperature of 25 ° C, after 30 seconds of spindle rotation. The compositions of the present invention are normally formulated to have a pH of 9.5 or less and, in general, have a pH in the range of about 4.5 to 9, more preferably, about 5 to 8.5. Some compositions, in particular those containing an additional active agent, such as, for example, salicylic acid, they require a lower pH so that the additional asset is completely effective. These compositions are normally formulated to have a pH of between about 2.5 and 5, more preferably between about 2.7 and 4.
Carrier The compositions of the present invention preferably comprise a safe and effective amount of a dermatologically acceptable carrier, suitable for topical application to the skin, within which essential materials, as well as other optional materials, are incorporated to achieve the materials Essentials and optional components are supplied to the skin at an appropriate concentration. The carrier can, in this way, act as a diluent, dispersant, solvent or the like for any of the active ingredients, which ensures that they can be applied and evenly distributed over the selected target surface, at an appropriate concentration. The compositions of the present invention comprise a continuous aqueous phase and, preferably, comprise an oil in water emulsion in which a hydrophobic phase, for example, a lipid, an oil or an oily material, is dispersed within the aqueous phase . In the technology of emulsions, the term "dispersed phase" is a term well known to any person skilled in the art, which means that the phase exists as small particles or droplets that are suspended in a continuous phase and surrounded by it. The dispersed phase is also known as the internal or discontinuous phase. Oil-in-water emulsions often comprise about 1% to 50% (preferably about 1% to 30%) of the hydrophobic dispersed phase and about 1% to 99% (preferably about 40% to 90%) ) of the continuous hydrophilic phase. The emulsion may also comprise a gel network, such as that described in G. M. Eccleston, Application of Emulsion Stabilitv Theories to Mobile and Semisolid O / W Emulsions. Cosmetics & Toiletries. Vol. 101, November 1996, p. 73-92, incorporated herein by reference. The carriers that have a very high preference are liquids or semi-sellers, such as creams, lotions and gels. Preferably, the carrier has the consistency of a lotion, cream or gel, with sufficient thickness or yield strength to prevent the particles from settling. The carrier itself may be inert or may offer dermatological benefits. The carrier must also be physically and chemically compatible with the essential components described here and must not excessively impair stability, efficacy or other benefits of use associated with the compositions of the present invention. The type of carrier used in the present invention depends on the types of product presentations that are desired for the composition. Topical compositions useful in the present invention can be prepared in a wide variety of product presentations, as those known in the art. They include, but are not limited to, lotions, creams, gels, sticks, sprays, ointments, pastes and foams. These product presentations may comprise various types of carriers including, but not limited to, solutions, aerosols, emulsions, gels, solids and liposomes. Preferred carriers contain a dermatologically acceptable hydrophilic diluent. Suitable hydrophilic diluents include water, organic hydrophilic diluents, such as monohydric alcohols C «| -C and low molecular weight polyols and glycols, among them: propylene glycol, polyethylene glycol (for example, with a MW of 200 to 600), polypropylene glycol (for example, with a MW of 425 to 2025), glycerol, butylene glycol, butane -1, 2, 4-triol, esters of sorbitol, hexane-1, 2,6-triol, ethanol, isopropanol, ethoxylated ethers, propoxylated ethers and combinations thereof. The diluent is preferably liquid. In particular, the preferred diluent is water. Preferably, the composition comprises at least about 60% of the hydrophilic diluent.
Emollients The topical compositions of the present invention comprise, in general, between about 1% and 50%, preferably about between 1.5% and 15% of a dermatologically acceptable emollient. Emollients tend to lubricate the skin, increase softness and flexibility of this, to avoid or alleviate the dryness of the skin and / or to protect it. Emollients are oily or waxy materials normally immiscible in water and emollients of high molecular weights can impart adherent properties to the topical composition. A wide variety of suitable emollients are known and can be used herein. Sagarin, Cosmetics, Science and Technology, 2nd edition, Vol. 1, p. 32-43 (1972), contains many examples of suitable materials as emollients. All the emollients described in the application WO 00/24372 can be considered as suitable for use in the present invention, although preferred examples are mentioned in more detail below: i) Straight or branched chain hydrocarbons having approximately 7 and 40 carbon atoms, such as, for example, dodecane, squalene, cholesterol, hydrogenated polyisobutylene, isohexadecane and the C7-C40 isoparaffins. which are C7-C40 branched hydrocarbons. ii) Alcoholic esters CJ-C3Q of C1-C30 carboxylic acids and of C2-C30 dicarboxylic acids, for example, isononyl isononanoate, isopropyl myristate, myristyl propionate, isopropyl stearate, isopropyl isostearate, methyl isostearate, behenate behenyl, dioctyl maleate, diisopropyl adipate and diisopropyl dilinoleate. iii) Mono and polyesters of sugars C < j-C3o and related materials. These esters are derived from a sugar or from a polyol entity and one or more carboxylic acid entities. Depending on the acid and constituent sugars, these esters can be liquid or solid at room temperature. Examples include: glucose tetraoleate, galactose tetraesters of oleic acid, sorbitol tetraoleate, sucrose tetraphasee, sucrose pentaoleate, sucrose hexaoleate, sucrose heptaoleate, sucrose octaoleate, sorbitol hexaester in which the ester entities of carboxylic acid are palmitoleate and arachididate in a molar ratio of 1: 2 and sucrose octaester where the esterifying carboxylic acid entities are laurate, linoleate and behenate in a molar ratio of 1: 3: 4. Other materials include fatty acid esters of cottonseed oil or soybean oil and sucrose. Other examples of these materials are described in WO 96/16636, incorporated herein by reference. A particularly preferred material is known by the name INCI of poly (cottonseed fatty acid ester) of sucrose. iv) Vegetable oils and hydrogenated vegetable oils. Examples of vegetable oils and hydrogenated vegetable oils include safflower oil, castor oil, coconut oil, cottonseed oil, shad oil, palm kernel oil, palm oil, peanut oil, soybean oil, rapeseed oil, flaxseed oil, rice bran oil, pine oil, sesame oil, sunflower seed oil, partial and totally hydrogenated oils of the aforementioned oils and mixtures thereof.
Emulsifiers / surfactants The compositions herein preferably contain an emulsifier and / or surfactant, generally to help disperse and suspend the discontinuous phase within the continuous aqueous phase. A surfactant may also be useful if the product is intended to be used for cleansing the skin. For convenience, the emulsifiers will be referred to hereinafter as "surfactants", thus, "surfactants" will be used to refer to surfactants, regardless of whether they are used as emulsifiers or for other purposes of agent action. surfactant, such as for cleaning the skin. The known or conventional surfactants can be used in the composition, as long as the selected agent is chemically and physically compatible with the essential components of the composition and provides the desired characteristics. Suitable surfactants include materials that are not derived from silicones and mixtures thereof. All surfactants presented in the application WO 00/24372 can be considered as suitable for the present invention. The compositions of the present invention preferably comprise approximately between 0.05% and 15% of a surfactant or mixtures of surfactants. The surfactant or the exact surfactant mixture chosen will depend on the pH of the composition and the other components present.
The preferred surfactants are the nonionic surfactants. Among the nonionic surfactants which are useful herein are those which can be defined in general as condensation products of long chain alcohols, for example, Cs-30 alcohols. with sugars or starch polymers, that is, glycosides.
Other useful nonionic surfactants include the condensation products of alkylene oxides with fatty acids (i.e., alkylene oxide esters and fatty acids). These materials have the general formula RCO (X) nOH, where R is an alkyl group C-J O-30. X is -OCH2CH2- (ie, derived from ethylene glycol or from ethylene oxide) or -OCH2CHCH3- (is said derivative of propylene glycol or of propylene oxide), and n is an integer of approximately between 6 and 200. Other nonionic surfactants are the condensation products of alkylene oxides with 2 moles of fatty acids (i.e. alkylene oxide and fatty acids). These materials have the general formula RCO (X) nOOCR, where R is an alkyl group C < ? o-30 > X is OCH2CH2- (ie, derivative of ethylene glycol or ethylene oxide) or OCH2CHCH3- (ie, propylene glycol or propylene oxide derivative) and n is an integer of between about 6 and 100. Other suitable additional examples include mixture of cetearyl alcohols, cetearyl glycosides, such as those available under the tradename Montanov 68 from Seppic.
The hydrophilic surfactants useful herein may alternatively or additionally include any of a wide variety of cationic, anionic, zwitterionic and amphoteric surfactants, such as are known in the art. Refer, for example, to McCutcheon's, Detergents and Emulsifiers, North American Edition (1986), published by Allured Publishing Corporation; United States Patent No. 5,011,681 of Ciotti et al., Granted on April 30, 1991; United States Patent No. 4,421, 769 of Dixon et al., Issued December 20, 1983, and United States Patent No. 3,755,560 to Dickert et al., Issued Aug. 28, 1973. A wide range of anionic surfactants are also useful herein. Refer, for example, to U.S. Patent No. 3,929,678, Laughiin et al., Issued December 30, 1975. A wide range of anionic surfactants are also useful herein. Refer, for example, to U.S. Patent No. 3,929,678, Laughiin et al., Issued December 30, 1975. Illustrative anionic surfactants include alkyl isethionates (eg, C 12 -C 30), alkyl and alkyl ether sulfates and alkyl salts, alkyl and alkyl ether phosphonates. and the salts thereof, alkylmethyltaurates (for example, C-J2-C30) and fatty acid soaps (for example, the alkali metal salts, for example, the sodium or potassium salts).
Zwitterionic and amphoteric surfactants are also useful herein. Examples of amphoteric and zwitterionic surfactants which can be used in the compositions of the present invention are those which are generally described as derivatives of secondary and tertiary aliphatic amines in which the aliphatic radical can be straight or branched chain and where one of the aliphatic substituents contain about 8 to 22 carbon atoms (preferably Cs-C < s) and one contains an anionic water solubilization group, eg, carboxyl, sulfonate, sulfate, phosphate, or phosphonate. Examples are the derivatives of alkyliminoacetates, iminodialcanoates and aminoalkanoates, imidazolinium and ammonium. Other suitable amphoteric and zwitterionic surfactants are those selected from the group consisting of branched and unbranched betaines, suitains, hydroxysultaines and alkanoylsarcosinates and mixtures thereof.
Thickening agent (including thickeners and gelling agents) The compositions of the present invention may also preferably comprise a thickening agent, more preferably between about 0.1% and 5%, with a greater preferehity between about 0.1% and 3% and most preferably approximately between 0.25% and 2% of a thickening agent.
Preferred compositions of the present invention include a thickening agent selected from carboxylic acid polymers, crosslinked polyacrylates, crosslinked polyacrylamides, xanthan gum and mixtures thereof, more preferably selected polyacrylamide polymers, xanthan gum and mixtures thereof. The preferred polyacrylamides are predispersed in a water-immiscible solvent, such as, for example, mineral oil and the like, which contains a surfactant (with an HLB of about 7 to 10) which helps facilitate the dispersion in water of the polyacrylamide. What is most preferred to be used herein is the non-ionic polymer with the CTFA designation: polyacrylamide and isoparaffin and laureth-7, which are available under the tradename Sepigel 305 from Seppic Corporation. Also useful are the copolymers of acrylic acid / ethyl acrylate and the carboxyvinyl copolymers, marketed by B.F. Goodrich Company with the trademark Carbopol resins. Suitable Carbopol resins are described in WO98 / 22085. All the thickening agents described in the application WO 00/24372 can be considered as suitable for use in the present invention.
Inorganic sunblocks In addition to organic sunblocks, the compositions of the present invention may additionally comprise sunscreens, physical, inorganic. The enunciative examples of blockers Suitable physical solar cells are described in the CTFA International Cosmetic Ingredient Dictionary, 6th edition, 1995, p. 1026-28 and 1103, Sayre, R. M. et al., "Physical Sunscreens", J. Soc. Cosmet. Chem., Vol 41, no. 2, pgs. 103-109 (1990). Inorganic physical sunblocks are zinc oxide and titanium dioxide, and mixtures thereof. When used, physical sunscreens are present in an amount such that the present compositions are transparent when applied to the skin (ie, they do not whiten the skin), preferably in an amount less than or equal to about 5%. When titanium dioxide is used, it may have an anatase, rutile or amorphous structure. Physical sunscreen particles, for example, titanium dioxide and zinc oxide, may be uncoated or coated with a variety of materials including, but not limited to, amino acids, aluminum compounds, such as alumina, aluminum stearate, aluminum laurate and the like; carboxylic acids and their salts, for example, stearic acid and its salts; phospholipids, such as lecithin; organic silicone compounds; inorganic silicone compounds, such as silica and silicates, and mixtures thereof. A preferred titanium dioxide can be obtained in commercial form from Tayca (Japan) and distributed by Tri-K Industries (Emerson, NJ) in the MT micro-ionized series (eg, MT 100SAS). The compositions of the present invention preferably comprise between about 0.1% and 10%, more preferably between about 0.1% and 4% and, with the greatest preference approximately between 0.5% and 2.5% by weight, of the inorganic sunblock.
Active agents for regulating skin condition The compositions of the invention optionally comprise a safe and effective amount of an active agent for regulating the condition or condition of the skin, which includes prophylactically and therapeutically regulating the condition of the skin. The prophylactic regulation of skin condition includes retarding, minimizing and / or avoiding visible and / or tactile discontinuities of the skin. The therapeutic regulation of skin components includes mitigating discontinuities, for example, by decreasing them, reducing them or eliminating them. The regulation of the state of the skin also includes the improvement of the appearance and / or the touch of the skin. Also included is the regulation of the signs of aging, which may involve the prophylactic regulation and / or therapeutic regulation of one or more of these signs, for example, fine lines, wrinkles, pores, and so on. The ingredients known to be useful for regulating skin condition are selected from vitamin B3 compounds, retinoids and combinations thereof. As already described for humectants, the aforementioned compounds, when used alone, generate a high level of adhesion, especially when used at high levels. However, it has been found that this tacky feel can be neutralized using the particulate materials of the present invention.
The compositions of the present invention preferably comprise between about 0.1% and 15%, more preferably between about 0.3% and 10% and with an even greater preference about between 1 and 5% of the active agent. In the sense that is used herein, the term "vitamin B3 compound" refers to a compound having the formula: where R is - CONH2 (ie, niacinamide), - COOH (ie, n-cotinic acid) or - CH2OH (ie, nicotinyl alcohol); derivatives thereof and the salts of any of them. In the present one or more of the compounds of vitamin B3 or their salts or mixtures can be used. In a preferred embodiment, the vitamin B3 compound normally contains less than about 50% of the compound in salt form. With the sense used herein, "retinoid" includes all natural and / or synthetic analogues of vitamin A or retinol-like compounds that possess the biological activity of vitamin A on the skin, as well as fos geometric isomers and stereoisomers of these compounds. Again, all the skin regulating materials described in the application WO 00/24372 can be considered as suitable for the present invention.
Anti-inflammatory Agents A safe and effective amount of an anti-inflammatory agent may be added to the compositions of the present invention, preferably about 0.1% to 5%, more preferably about 0.1% to 2% of the composition. The anti-inflammatory agent increases the appearance benefits of the skin of the present invention, for example, these agents contribute to a more uniform and acceptable skin tone and color. The exact amount of the anti-inflammatory agent that will be used in the compositions will depend on the particular anti-inflammatory agent used, since the potency of these agents varies widely. Antiinflammatory agents useful herein include steroids such as hydrocortisone; non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, panthenol and ether and ester derivatives thereof, for example panthenol, panthenol triacetate; pantothenic acid and salts and ester derivatives thereof, especially calcium pantoiænate, aloe vera or aloe vera, bisabolol, afantoin and compounds of the orozus family (the plant of the genus / species Glycyrrhiza glabra), which include glycyrrhizic acid , glycyrrhizic acid, and derivatives thereof, for example, salts such as ammonium glycyrrhizinate and esters such as stearyl glycyrrheinate. Particularly preferred in the present are: panthenol, pantothenic acid and its ether, ester or salt derivatives and mixtures thereof; Appropriate levels range from approximately between 0.1 and 5%, preferably approximately between 0.5 and 3%. In particular, panthenol is preferred.
Antioxidants / radical scavengers The compositions of the present invention may further include an antioxidant / radical scavenger. The antioxidant / radical scavenger is especially useful to provide protection against UV radiation, which can cause an increase in healing or texture changes in the stratum corneum, and useful against other environmental agents that can cause skin damage. Suitable amounts are between about 0.1% and 10%, more preferably between about 1% and 5% of the composition.
Antioxidants / radical scavengers Antioxidants / radical scavengers such as ascorbic acid (vitamin C) and its salts, fatty acid ascorbyl esters, ascorbic acid derivatives (eg, magnesium ascorbyl phosphate), beta-carotene may be used. , tocopherol (vitamin E), tocopherol sorbate, tocopherol acetate, other tocopherol esters, butylated hydroxybenzoic acids and their salts, gallic acid and its alkyl esters, especially propyl gallate, uric acid and its salts and esters of alkyl, sorbic acid and its salts, amines (e.g., N, N-diethylhydroxylamine, aminoguanidine), sulfhydryl compounds (e.g., glutathione), acid dihidroxifumárico and its salts, bioflavonoides, lysine, methionine, proline, superoxide dismutase, silymarin, tea extracts, shell extracts / grape seeds, melanin and rosemary extracts. Preferred antioxidants / radical scavengers are selected from tocopherol acetate, tocopherol sorbate and other tocopherol esters, more preferably, tocopherol acetate. As described for humectants, the aforementioned compounds, when used alone, generate a high level of adhesion, especially when used at high levels. However, it has been found that this sticky feel can be neutralized using the particulate materials of the present invention.
Chelating agents The inclusion of a chelating agent is especially useful to provide protection against UV radiation, which can contribute to excessive scarring or changes in the texture of the skin, and useful against other environmental agents that can cause skin damage. A suitable amount is between about 0.01% and 1%, more preferably between about 0.05% and 0.5% of the composition. Chelating agents that are useful herein are presented in U.S. Pat. 5,487,884, incorporated herein by reference. Preferred chelating agents that are useful in the compositions of the present invention are ethylenediaminetetraacetic acid (EDTA), furyldioxime and derivatives thereof.
Peeling / Exfoliating Agents A safe and effective amount of a desquamation agent may be added to the compositions of the present invention, preferably between about 0.1% and 10%, with an even greater preference between about 0.2% and 5%, also prefers approximately between 0.5% and 4% of the composition. The desquamation agents increase the skin appearance benefits provided by the present invention. For example, desquamation agents tend to improve the texture of the skin (for example, the softness). A variety of desquamation agents are known in the art and are suitable for use herein, including organic hydroxy acids, such as, for example, salicylic acid, glycolic acid, lactic acid, 5-octanoylsalicylic acid, hydroxyoctanoic acid, hydroxycaprylic acid and fatty acids. of lanolin. A desquamation system which is suitable for use herein comprises sulfhydryl compounds and zwitterionic surfactants and is described in WO 96/01101, hereby incorporated by reference. Another desquamation system which is suitable for use herein includes salicylic acid and zwitterionic surfactants and is described in WO 95/13048, incorporated herein by reference. Salicylic acid is preferred.
Skin lightening agents The compositions of the present invention may also comprise a skin lightening agent. When used, the compositions preferably comprise between about 0.1% and 10%, more preferably between about 0.2% and 5%, and also about between 0.5% and 2% of a skin lightening agent. Skin lightening agents include those known in the art, including kojic acid, arbutin, ascorbic acid and derivatives thereof, for example, magnesium ascorbyl phosphate. Additionally, skin lightening agents, suitable for use herein, also include those described in WO 95/34280 and WO 95/23780; which are incorporated herein by reference.
Silicone Based Ingredients The compositions of the present invention preferably also contain silicone-based ingredients. The preferred examples are described below: 2) Emollients with silicone base In the present compositions, organopolysiloxane oils can be used as ingredients with emollient benefits. Suitable organopolysiloxane oils include volatile, non-volatile silicones or a mixture of volatile and non-volatile silicones. The term "non-volatile" that is used in this context refers to silicones that are liquid at ambient conditions and that have a flash point, also called the temperature of inflammation (at an atmosphere of pressure) equal to or less than about 100 ° C. The term "volatile" that is used in this context refers to silicone oils that have a flash point less than 100 ° C. Suitable organopolysiloxanes can be selected from a wide variety of silicones having a wide range of volatilities and viscosities. Non-volatile polysiloxanes are preferred. Suitable silicones are presented in U.S. Pat. 5,069,897, granted on December 3, 1991, which is incorporated herein by reference in its entirety. For this invention it is preferred to use the organopolysiloxanes selected from the group consisting of: polyalkylsiloxanes, alkyl-substituted dimethicones, dimethiconols, polyalkylarylsiloxanes and mixtures thereof. In the present, the greatest preference of use is for polyalkylsiloxanes and cyclomethicones. Among the preferred polyalkylsiloxanes are the dimethicones, for example, the DC200 obtainable from Dow Corning and the SF96 obtainable from GE Silicone. ii) Silicone based emulsifiers Preferred emulsions of the present invention include an emulsifier or silicone-containing surfactant. A wide variety of silicone emulsifiers are useful herein. These emulsifiers of silicone are usually organopolysiloxane organically modified, also known as silicone surfactants by those skilled in the art. Useful silicone emulsifiers include dimethicone copolyols. These materials are polydimethylsiloxanes that have been modified to include polyether side chains, such as polyethylene oxide chains, polypropylene oxide chains, mixtures of these chains and polyether chains containing entities derived from both ethylene oxide and polyether oxide. propylene. Other examples include alkyl-modified dimethicone copolyols, ie, compounds containing pendant C2-C30 side chains. Other useful dimethicone copolyols include materials having various cationic, anionic, amphoteric and zwitterionic pendant entities.
Preparation of the compositions The present invention relates to cosmetic compositions having a continuous aqueous phase comprising an organic particulate material, more than 8% humectant and organic sunscreen. The compositions are preferably an oil in water emulsion. They can be prepared in accordance with the procedures normally used for cosmetics, which those skilled in the art know and understand well, wherein materials having a similar phase separation can be added in any order.
Preferably, the organic particulate material is premixed slowly and homogeneously in a carrier oil, before being added to the remainder of the composition. This results in that the organic particulate material can more efficiently neutralize the adverse adhesion properties of the beneficial agents for the foot, as compared to a process where the particulate material is added directly to the composition. Once the premix has been formed, it should preferably be added immediately to the rest of the composition to maintain its benefits. If the rest of the composition is an emulsion, then it is preferred to prepare the emulsion before adding the premix. This avoids the disturbance of the premix which could potentially occur as a result of the step applying a high shear stress during the emulsification.
Composition of the premix The premix preferably comprises between about 5% and 90%, more preferably between about 20% and about 80% and more preferably between about 40% and about 75% by weight of the organic particulate material. Preferably, it has a viscosity of less than 5000 mPa.s, preferably less than 2000 mPa.s, which is measured using a Haake Rheostress RS75 rheometer that uses air and uses a C35 / 2TÍ cone and plate and a separation distance of 0.105 mm. . The viscosity was measured at 31 ° C (skin temperature) at a shear stress of 20s "1. it is preferred that the premix be formed and remain stable within a discrete phase, within the remainder of the composition, so that it can be seen as different droplets, with a diameter greater than 0.1 μm, when viewed with a 40x magnification using a standard optical microscope. However, it is recognized that, depending on the other ingredients of the composition, there may be migration of several of the other ingredients, from one phase to another, once the composition is formed, which may prevent maintenance of the premix as a true discrete phase.
Carrier Oil It is preferred that the carrier oil have a surface tension less than that of the chosen organic particulate and a viscosity less than about 350 mPa.s, preferably less than about 100 mPa.s, more preferably less than about 75 mPa. s. The viscosity of the carrier oil was also measured at 31 ° C (skin temperature), in the same manner as described for the entire premix. The carrier oil is preferably an organosilicon-based oil, selected from volatile and non-volatile organosi-loxanes and mixtures thereof. The term "non-volatile" as used in this context, refers to silicones that are liquid at ambient conditions and that have a flash point, also called flash point (at a pressure atmosphere) equal to or less than about 100 ° C. The term "volatile" that is used in this context is refers to silicone oils that have a flash point less than 100 ° C. Suitable organopolysiloxanes can be selected from a wide variety of silicones having a wide range of volatilities and viscosities. Non-volatile organopolysiloxanes are preferred. In U.S. Patent No. 5,069,897, issued on December 3, 1991, the oils of silicone carriers are exposed. Here, it is preferred to use the organopolysiloxanes selected from the group consisting of: polyalkylsiloxanes, alkyl-substituted dimethicones, dimethiconols, polyalkylarylsiloxanes and mixtures thereof. In the present, the greatest preference of use is for polyalkylsiloxanes and cyclomethicones. Among the preferred polyalkylsiioxanes are the dimethicones, for example, the DC200 obtainable from Dow Corning and the SF96 obtainable from GE Silicone.
EXAMPLES The following examples further illustrate the preferred embodiments within the scope of the present invention. These examples are provided for illustrative purposes only and should not be construed as limiting the present invention, as many variations of the invention are possible without departing from the spirit or scope thereof. Unless otherwise indicated, all ingredients are expressed as a percentage by weight of the active ingredient.
PHASE! PHASE II PHASE III Additional ingredients 1. Supplied by Hoffmann-LA Roche, Inc., 340 Kingsland Street, Nutley, NJ 07110-1199 2. Supplied by BASF Aktiengesellschaft, MEM / KU-D 205, 67056 Ludwigshafen, Germany 3. Supplied by Haarmann & Reimer Coforation, 70 Diamond Road, P. O. Box 175, Springfield, NJ 07081-0175 4. PEG 100 Stearate supplied by ICI, PO Box 90, Wilton Center, Middlesborough, Cleveland, England. TS6 8JE 5. Supplied by Scher Chemicals Inc., Industrial West, Clifton, NJ 07012 6. A mono-ester or polyester C1-C30 of sugars and one or more carboxylic acid entities, as described herein, preferably, a polyester of sucrose in which the degree of esterification is from 7 to 8 and in which the fatty acid entities are C18 mono and / or diunsaturated and behenic, in a molar ratio of unsaturated: behenic from 1: 7 to 3: 5, more preferably, the sucrose octaester in which there are approximately 7 behenic fatty acid entities and approximately 1 oleic acid entity in the molecule, for example, sucrose ester of cottonseed oil fatty acids. 7. Supplied by Kobo Products Inc., 690 Montrose Ave, So Plainfield, NJ 07080 8. Supplied by Union Carbide Corporation, Danbury, Conn., USA. 9. Supplied by Seppic, 75 Quai D'Orsay, Paris 10. Supplied by Cognis UK Ltd., 3th. Floor, Eleanor House, 33/35 Eleanor Cross Road, Waltham Cross, EN8 7LE, UK 11. Supplied by Shamrock Technologies Inc., Newark, NJ07114, USA. 12. Supplied by GE Silicones, Plasticslaan 1 / PO Box 117, 4600 BC Bergen op Zoom, The Netherlands 13. Supplied by Elf Atochem, 4, cours Michelet, La Defense 10, Cedex 42, 92091, Paris 14. Supplied by Dow Corning, Kings Court, 185 Kinds Rd, Reading, Berks, RG1 4EX 15.Octenil Aluminum and cotton succinate supplied by National Starch and Chemical Limited, Braunston, Daventry, Northants, NN11 7KL, UK. Phase I was prepared by mixing the oil-soluble emulsifiers, emollients and oil-soluble preservatives with gentle heating until a homogeneous mixture formed. Phase II was prepared by heating water, glycerin, Kobo titanium dioxide, urea, polyethylene glycol, hexane-1,2,6-triol in a vessel to approximately 80 ° C, while mixing with a paddle turbine mixer. Heidolph step to 200 fm, cooling to 75 ° C and adding Montanov 68 and disodium EDTA. Stirring was continued for a further 5 minutes before the addition of phase I. The mixture from phase I to phase II was homogenized using Ultraturax T25 equipment (IKA-Labortechnik) at 13500 fm for about 10 minutes and then cooled to 65 ° C. If required, the particulate material of phase III was stirred in the carrier oil at room temperature with an impeller stirrer at 50-150 rpm. Once a homogeneous mixture was formed, it was added immediately to the phase I / phase II emulsion. In cases where in the In phase III there was no carrier oil present, the particulate material was added slowly, with stirring, to the phase I / phase II emulsion. The resulting mixture was cooled for a longer time and as soon as it reached 60 ° C, Sepigel 305 and NaOH were added. The rest of the ingredients were added after the mixture was further cooled to 50 ° C. The resulting product was cooled longer before packaging.

Claims (19)

  1. NOVELTY OF THE INVENTION CLAIMS 1. A cosmetic composition for topical use with a continuous aqueous phase, such as a lotion, cream or gel characterized in that it comprises: i) from 0.01% to 25% by weight, of an organic particulate material having a median particle size from 0.5 up to 30 μm; ii) more than 8% by weight, of a humectant selected from: glycerin, polyalkylene glycol, urea, panthenol D or DL, hexane-1, 2, 6-triol, guanidine or its derivatives, aikylene glycols, such as butylene glycol and propylene glycol, and mixtures thereof; iii) from 2% to 20% by weight, of organic sunscreen. The composition according to claim 1, further characterized in that the organic particulate material has a median particle size of 0.5 to 15 μm, preferably 0.7 to 10 μm and most preferably 1 to 7.5 μm. 3. The composition according to any of claims 1 or 2, further characterized in that the organic particulate material is selected from: polymers of organosilicon, polyethylene, polyacrylonitrile, polyacrylic acid, polymethacrylic acid, polystyrene, polytetrafluoroethylene, polyvinylidene chloride ), • polyamide and copolymer of ethylene and acrylic acid and mixtures thereof. 4. The composition according to any of claims 1 to 3, further characterized in that the organic particulate material is selected from organosilicon polymers and mixtures thereof and, more preferably, from polymethyl silsesquioxane. The composition according to any of claims 1 to 4, further characterized in that the organic particulate material has a critical surface tension less than 50 mN / m, preferably less than 40 mN / m and more preferably less than 35 mN / m. 6. The composition according to any of claims 1 to 5, further characterized in that it comprises 0.1% a 15%, more preferably from 0.2% to 5% by weight, of organic particulate material. The composition according to any of claims 1 to 6, further characterized in that the humectant is selected from glycerin or urea and mixtures thereof. The composition according to any of claims 1 to 7, further characterized in that it comprises from 8% to 30%, more preferably from 8.5% to 20% and most preferably from 9% to 15% by weight, of the humectant 9. The composition according to any of claims 1 to 8, further characterized in that the organic sunscreen is selected from compounds with UVA-absorbing properties. or compounds with UVB-absorbing properties and mixtures thereof. 10. The composition according to claim 9, further characterized in that the organic sunscreen that absorbs the UVA radiation is a derivative of dibenzoylmethane and mixtures thereof and, preferably, butylmethoxydibenzoylmethane. The composition according to claim 9, further characterized in that the organic sunscreen absorber of UVB radiation is selected from: octocriene, octomethoxy cinnamate, octyl salicylate, phenylbenzimidazole sulfonic acid or mixtures thereof, preferably octocrylene . The composition according to any of claims 1 to 11, further characterized in that it comprises from 4% to 14% by weight, of the organic sunblock. 13. The composition according to any of claims 1 to 12, further characterized in that the sun protection factor is greater than 10, preferably greater than 15, and where the critical absorption wavelength is greater than 370 nm. The composition according to any of claims 1 to 13, further characterized in that it comprises from 0.1% to 20%, preferably from 0.2% to 10%, more preferably from 0.5% to 5% by weight, of niacinamide. 15. The composition according to any of claims 1 to 14, characterized also because it is an oil in water emulsion. 16. The composition according to any of claims 1 to 15, further characterized in that the particulate material is previously dispersed in an organosiloxane oil and in which the premix has a viscosity of less than 5000 cps, preferably less than 2000 cps. , at 31 ° C to 20 ° C. The composition according to any of claims 1 to 16, further characterized in that the liquid dispersion of organosiloxane oil has a viscosity of less than 350 mPa.s, preferably less than 100 mPa.s and, more preferably, less than 75 mPa.s, at 31 ° C to 20s "1. 18. The use of the composition of any of claims 1 to 17, wherein the organosiloxane oil is preferably dimethicone. 19. The use of the composition as claimed in claims 1 to 18 to provide high levels of wetting and protection against UV radiation with lower levels of adhesion or tack.
MXPA02011623A 2000-05-23 2001-05-14 Skin care moisturizing and sunscreen compositions comprising organic particulate material. MXPA02011623A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0012565A GB0012565D0 (en) 2000-05-23 2000-05-23 Skin care compositions
GB0023336A GB0023336D0 (en) 2000-09-22 2000-09-22 Skin care compositions
GB0024372A GB0024372D0 (en) 2000-10-05 2000-10-05 Skin care compositions
PCT/US2001/015596 WO2001089466A1 (en) 2000-05-23 2001-05-14 Skin care moisturizing and sunscreen compositions comprising organic particulate material

Publications (1)

Publication Number Publication Date
MXPA02011623A true MXPA02011623A (en) 2003-03-27

Family

ID=27255736

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02011623A MXPA02011623A (en) 2000-05-23 2001-05-14 Skin care moisturizing and sunscreen compositions comprising organic particulate material.

Country Status (10)

Country Link
EP (1) EP1292276A1 (en)
JP (1) JP2003534260A (en)
KR (1) KR100543824B1 (en)
CN (1) CN1430500A (en)
AU (2) AU2001263125B2 (en)
BR (1) BR0111113A (en)
CA (1) CA2408700A1 (en)
CZ (1) CZ20023832A3 (en)
MX (1) MXPA02011623A (en)
WO (1) WO2001089466A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3596534B2 (en) * 2002-03-14 2004-12-02 富士ゼロックス株式会社 Emulsified cosmetic
US20030228335A1 (en) * 2002-06-06 2003-12-11 Suess Hans R. Method for improving sensory characteristics of semisolid predominantly anhydrous lipids
DE10226349A1 (en) * 2002-06-13 2003-12-24 Beiersdorf Ag Cosmetic and dermatological light protection preparations containing a combination of UV absorbers and spherical silicon oxides
AR045504A1 (en) 2003-08-28 2005-11-02 Shell Int Research RAMOSED ESTER COMPOSITION
US20050175575A1 (en) * 2004-02-11 2005-08-11 Yun Xu Shaving compositions
FR2873020A1 (en) * 2004-07-13 2006-01-20 Oreal Composition for manufacturing cosmetic product e.g. sun protection product comprises aqueous phase, hydrophilic inorganic nanopigments based on metal oxides and polyalkylene glycol with specified mean molecular mass; in physiological medium
WO2006005630A1 (en) * 2004-07-13 2006-01-19 L'oreal Aqueous photoprotective composition comprising hydrophilic metal oxide nanopigments and a polyalkylene glycol of low molecular mass; uses
KR100557196B1 (en) 2004-09-21 2006-03-03 엔프라니 주식회사 Composition with high moisturing effects, method for nano-capsulating the same and cosmetic composition containing the nano-capsulated composition
DE102004060541A1 (en) * 2004-12-15 2006-06-29 Degussa Ag Process for the preparation of alkanediols and alkanetriols having a vicinal diol group
DE102008013804A1 (en) 2008-03-10 2009-09-17 Beiersdorf Ag Foundation with UV filter combination
DE102008013805A1 (en) 2008-03-10 2009-09-17 Beiersdorf Ag Foundation with particulate organic sunscreen
JP2010111626A (en) * 2008-11-06 2010-05-20 Kao Corp Sunscreen cosmetic
JP5368069B2 (en) * 2008-11-21 2013-12-18 花王株式会社 Sunscreen cosmetics
FR2939669B1 (en) * 2008-12-17 2011-03-25 Oreal COSMETIC METHOD FOR CONTROLLING SKIN BLIND INDUCED BY UV RADIATION; Compositions.
KR101134765B1 (en) * 2009-10-01 2012-04-13 (주)아모레퍼시픽 Cosmetic composition enhancing skin luminosity and transparency
JP2010090153A (en) * 2009-12-10 2010-04-22 Kao Corp Gel-like cosmetic
KR101275351B1 (en) * 2010-06-29 2013-06-17 (주)아모레퍼시픽 Cosmetic Composition for Preventing Skin Aging
KR101230380B1 (en) * 2011-02-09 2013-02-07 전주대학교 산학협력단 Nano-emulsion containing niacinamide and cosmetic composition comprising the same
ES2393028B1 (en) * 2011-03-24 2013-11-05 Martín BAENA JIMÉNEZ PROCEDURE FOR OBTAINING A HAND CREAM.
ES2395011B1 (en) * 2011-03-25 2013-12-27 Martín BAENA JIMÉNEZ PROCEDURE FOR OBTAINING A BODY MILK
GB201122220D0 (en) * 2011-12-23 2012-02-01 Croda Int Plc Novel emoillients
DE102012203307A1 (en) * 2012-03-02 2013-09-05 Evonik Industries Ag Use of powdered cellulose in cosmetics
JP2015515500A (en) * 2012-05-03 2015-05-28 ザ プロクター アンド ギャンブルカンパニー Oil-in-water emulsion skin care composition
ES2483599B2 (en) * 2014-05-26 2015-03-31 Sipcam Inagra, S.A. Synergistic Surfactant Composition
CA3011986A1 (en) * 2016-01-22 2017-07-27 Edgewell Personal Care Brands, Llc Hydrophobic topical compositions
KR101825683B1 (en) * 2017-05-12 2018-02-05 주식회사 라비오 Protective cosmetic composition for antiinflammatory uv induced damage
BR112020012422B1 (en) * 2017-12-19 2023-12-26 Dsm Ip Assets B.V TOPICAL COMPOSITION, RELATED USE AND METHOD FOR REDUCING THE TRANSFER OF FAT OR OIL TO A SURFACE

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3382566D1 (en) * 1982-09-30 1992-07-02 Lancaster Group Ag GLYCER-CONTAINING COSMETIC AGENTS.
ZA861309B (en) * 1985-02-28 1986-10-29 Procter & Gamble Sunscreen compositions
JPH06122613A (en) * 1992-10-12 1994-05-06 Kao Corp Emulsion cosmetic
US5505935A (en) * 1994-05-09 1996-04-09 Elizabeth Arden Company, Division Of Conopco, Inc. Sunscreen compositions
JP3579778B2 (en) * 1995-12-28 2004-10-20 株式会社コーセー Sun care cosmetics
JP3537622B2 (en) * 1996-02-26 2004-06-14 株式会社資生堂 UV absorbing composition
JPH09227350A (en) * 1996-02-26 1997-09-02 Shiseido Co Ltd Uv rays absorbing skin cosmetic
JPH09227351A (en) * 1996-02-26 1997-09-02 Shiseido Co Ltd Uv rays absorbing skin cosmetic
JPH09249545A (en) * 1996-03-12 1997-09-22 Shiseido Co Ltd Skin preparation for external use
ES2205230T3 (en) * 1996-04-23 2004-05-01 THE PROCTER &amp; GAMBLE COMPANY METHODS TO REGULATE THE ASPECT OF THE SKIN WITH A VITAMIN B3 COMPOUND.
DE69732464T2 (en) * 1996-10-03 2006-05-11 Shiseido Co. Ltd. External gel-based skin care product
FR2759583B1 (en) * 1997-02-17 1999-12-10 Oreal ANTISOLAR COMPOSITION CONTAINING A SOLID ORGANOPOLYSILOXANE ELASTOMERIC
FR2768926B1 (en) * 1997-10-01 2000-01-28 Oreal STABLE TOPICAL COMPOSITION CONTAINING A SOLID ORGANOPOLYSILOXANE ELASTOMERIC AND SPHERICAL PARTICLES
JPH11236307A (en) * 1997-12-13 1999-08-31 Kose Corp Cosmetic material
US5972316A (en) * 1998-10-16 1999-10-26 The Procter & Gamble Company UV protection compositions
AU1275599A (en) * 1998-10-23 2000-05-15 Procter & Gamble Company, The Skin care compositions
EP1213006B1 (en) * 1999-08-30 2007-12-05 Kanebo Cosmetics Inc. Use of the organopolysiloxane M3T in cosmetic compositions

Also Published As

Publication number Publication date
KR100543824B1 (en) 2006-01-23
JP2003534260A (en) 2003-11-18
BR0111113A (en) 2003-04-08
AU6312501A (en) 2001-12-03
WO2001089466A1 (en) 2001-11-29
CN1430500A (en) 2003-07-16
AU2001263125B2 (en) 2005-10-20
CZ20023832A3 (en) 2003-04-16
EP1292276A1 (en) 2003-03-19
KR20030005390A (en) 2003-01-17
CA2408700A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
MXPA02011623A (en) Skin care moisturizing and sunscreen compositions comprising organic particulate material.
AU2001263125A1 (en) Skin care moisturizing and sunscreen compositions comprising organic particulate material
US20030113357A1 (en) Skin Care Compositions
US5980871A (en) Sunscreen compositions
JP5837868B2 (en) Photoprotective composition comprising a synergistic combination of sunscreen active compounds
US20080038216A1 (en) Personal care composition
WO2010110020A1 (en) Sunscreen cosmetic
JP7053638B2 (en) Sunscreen composition with natural wax to improve water resistance
TWI386227B (en) Cosmetic composition
MXPA01012207A (en) Niacinamide compositions with reduced tack.
EP1660021A2 (en) Emulsion composition
CA2813094C (en) A sunscreen composition
CA2119434C (en) Compositions containing sunscreens
US20040126337A1 (en) Sunscreen compositions
JP7152161B2 (en) External skin preparations or cosmetics
JP2010510187A (en) Cosmetic composition
CA3095131A1 (en) Process for the preparation of a base formulation for a dermatological sunscreen composition and for the preparation of a dermatological sunscreen composition
JP2009234933A (en) Skin external preparation
US10556134B2 (en) Stable personal care cream composition
GB2278055A (en) Compositions containing sunscreens
AU739377B2 (en) Sunscreen compositions
JP2021059535A (en) Transparent sunscreen composition
JP2021161077A (en) Aqueous cosmetic
MXPA00012003A (en) Sunscreen cosmetic composition